Cargando…
Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease
BACKGROUND: Patients with chronic kidney disease (CKD) present an imbalance of the gut microbiota composition, leading to increased production of uremic toxins like p-cresyl sulfate (PCS), product from bacterial fermentation of the amino acids tyrosine (Tyr) and phenylalanine (Phe) from the diet. Th...
Autores principales: | Fernandes, Andressa Louzada Frauche, Borges, Natalia A., Black, Ana Paula, dos Anjos, Juliana, da Silva, Greicielle Santos, Nakao, Lia S., Mafra, Denise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657053/ https://www.ncbi.nlm.nih.gov/pubmed/32459280 http://dx.doi.org/10.1590/2175-8239-JBN-2018-0214 |
Ejemplares similares
-
p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017) -
p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
por: Hyun, Hye Sun, et al.
Publicado: (2013) -
Molecular and Cellular Mechanisms that Induce Arterial Calcification by Indoxyl Sulfate and P-Cresyl Sulfate
por: Opdebeeck, Britt, et al.
Publicado: (2020) -
The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients
por: Wu, Ping-Hsun, et al.
Publicado: (2021) -
Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)